You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Covid cases in Kerala likely to come down in next 2 weeks: AIIMS professor

Kerala has passed its COVID-19 peak and in the next 2 weeks, a decline in cases should start in the state, said Dr Sanjay Rai, AIIMS Professor on Tuesday.

Topics
Coronavirus | AIIMS | Kerala

ANI 

Kerala
(File photo: PTI)

has passed its COVID-19 peak and in the next 2 weeks, a decline in cases should start in the state, said Dr Sanjay Rai, Professor on Tuesday.

Rai told ANI, "Earlier sero survey in suggest that most population was susceptible but latest sero survey shows that 46 per cent had antibodies due to vaccine or by infection. The measures are taken by the state only slows down the spread. By looking at the data of the virus spread in last 2-3 months, has passed its peak and in the next 2 weeks, a decline in cases should start. Just like North-East, Kerala should also start witness drop in COVID cases by the start of October as per the epidemiological picture."

will be starting Phase 2/3 trials of Hyderabad-based COVID-19 vaccine manufacturer Bharat Biotech's nasal vaccine soon and the application has been put to seek the mandatory permission of the Ethics Committee.

"It is very early to say but we believe that future is promising for Nasal Vaccine as it can provide mucosal immunity, then infection prevention is possible. Most of the vaccines are not able to stop the infection, they only reduce the severity. The Nasal vaccine has gone for ethical approval and after the approval, we will start the trial," said Dr Rai, who is also Bharat Biotech's nasal vaccine clinical trial's principal investigator.

The adenoviral intranasal vaccine BBV154 is the first of its kind COVID-19 vaccine to undergo human trials in India.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, September 15 2021. 09:14 IST
RECOMMENDED FOR YOU